Form D · Venture Capital Fund
Pharmacy Innovator Fund, a Series of Decile Start Fund, LP
New York, NY · CIK 0002125678
Offering snapshot reported Apr 27, 2026 · SEC filing
- Reported sold
- $410K Offering amount: $410K
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 6, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 27, 2026 | Initial | $410,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06c, 3C, 3C.1
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-581927
Source: Form D, filed Apr 27, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Decile Start Fund Gp, Llc | Executive |
| Decile Start Fund Management, Llc | Executive |
| Long Pham | Director, Executive |
| Gregory Adeodato Ressi Di Cervia | Director, Executive |
| Christian Tadrus | Promoter |
| Tadrus Advisory Group, Llc | Promoter |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
575 Lexington Ave 14 Th Floor
New York, NY, 10022
New York, NY, 10022